Metagenomi Therapeutics, Inc. (MGX) Net Margin
- 2026-03-31: Net Margin -1847.68%.
- 2025-12-31: Net Margin -576.02%.
- 2025-09-30: Net Margin -235.51%.
- 2025-06-30: Net Margin -233.85%.
Complete source-backed net margin history.
- Available history
- 2023-03-31 to 2026-03-31
- Data captured
Historical Net Margin
| Date | Net Margin |
|---|
| 2026-03-31 | -1847.68% |
|---|
| 2025-12-31 | -576.02% |
|---|
| 2025-09-30 | -235.51% |
|---|
| 2025-06-30 | -233.85% |
|---|
| 2025-03-31 | -606.71% |
|---|
| 2024-12-31 | -243.37% |
|---|
| 2024-09-30 | -163.04% |
|---|
| 2024-06-30 | -53.67% |
|---|
| 2024-03-31 | -225.36% |
|---|
| 2023-12-31 | -155.61% |
|---|
| 2023-09-30 | -160.32% |
|---|
| 2023-06-30 | -114.74% |
|---|
| 2023-03-31 | -186.36% |
|---|
Annual Net Margin
| Date | Net Margin |
|---|
| 2025-12-31 | -348.54% |
|---|
| 2024-12-31 | -149.26% |
|---|
| 2023-12-31 | -152.50% |
|---|